With Lilly on board, Entos’ medical chief champions genetic platform with ‘unlimited’ potential

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Entos Pharmaceuticals is on the verge of “leveling up,” and Steve Chen is excited to help them get there. “I think the company right now is actually going through what I would call a major inflection point,” … Read more